Assistant Professor at MSA University, Egypt
Dr. Karim Anasr is a highly accomplished biochemist with a strong academic background and extensive experience in research and education. He holds a Ph.D. in Biochemistry from Cairo University and has worked as a lecturer in various prestigious institutions. Dr. Anasr’s research focuses on the molecular mechanisms underlying liver diseases and the potential therapeutic interventions, particularly in the context of cancer. He has made significant contributions to the field through his publications and active participation in conferences and professional development activities.
Author Metrics:
Scopus Profile
ORCID Profile
Google Scholar Profile
Dr. Anasr’s contributions to the scientific community are notable, as evidenced by his author metrics. He has published several articles in reputable journals, and his research has been cited by peers in the field. Additionally, he has presented his work at conferences, further demonstrating his impact and engagement within the scientific community.
- Citations: 33
- Documents: 5
- h-index: 2
Karima Mahmoud Nasraldin is affiliated with the Faculty of Biotechnology in 6th October, Egypt. Her Scopus Author Identifier indicates an ORCID profile linked to her publications. With 33 citations across 5 documents, she has contributed significantly to the field. Her h-index, which measures both the productivity and impact of her research, stands at 2.
Education:
Dr. Anasr obtained his Ph.D. in Biochemistry from Cairo University, where he conducted research on the effects of Amygdalin and milk thistle extract on HepG2 cell lines. Prior to his Ph.D., he completed his Master’s and Bachelor’s degrees in Biochemistry, further solidifying his expertise in the field.
Research Focus:
Dr. Anasr’s research primarily focuses on understanding the molecular mechanisms involved in liver diseases, particularly hepatocellular carcinoma. He investigates the potential therapeutic effects of natural compounds and vitamins, such as Amygdalin and cholecalciferol, on cancer cell lines. His work aims to identify novel treatment strategies and biomarkers for liver diseases.
Professional Journey:
Dr. Anasr’s professional journey has been marked by continuous growth and achievement. Starting as a Teaching Assistant, he has progressed through various academic positions, including Assistant Lecturer and Lecturer, at esteemed institutions such as Cairo University and the British University In Egypt. Alongside his teaching responsibilities, he has actively engaged in research, contributing significantly to the advancement of biochemistry.
Honors & Awards:
Throughout his career, Dr. Anasr has received recognition for his academic and research achievements. He has been awarded honors for his outstanding performance during his Bachelor’s and Master’s degrees. Additionally, his research has garnered attention, leading to awards and accolades at conferences and within the scientific community.
Publications Noted & Contributions:
Dr. Anasr’s publications have made significant contributions to the field of biochemistry, particularly in the study of liver diseases. His research articles have been published in reputable journals and have been cited by peers, highlighting their impact and relevance. Additionally, he has presented his work at conferences, further disseminating his findings and contributing to scientific discourse.
“The Postulated Mechanism of Action of Amygdalin (Vitamin B17) on Cancer Cells”
- Journal: Anti-Cancer Agents in Medicinal Chemistry
- Publication Date: May 2023
- DOI: 10.2174/1871520623666221124143751
- Contributors: Abdelgawad Ali Fahmi, Mohamed Ali El-Desouky, Karima Mahmoud Nasraldin
“Anticancer Effect of Amygdalin (Vitamin B-17) on Hepatocellular Carcinoma Cell Line (HepG2) in the Presence and Absence of Zinc”
- Journal: Anti-Cancer Agents in Medicinal Chemistry
- Publication Date: May 15, 2020
- DOI: 10.2174/1871520620666200120095525
- Contributors: Mohamed A. El-Desouky, Abdelgawad A. Fahmi, Ibrahim Y. Abdelkader, Karima M. Nasraldin
“Anticancer effect of Amygdalin (vitamin B17) on hepatocellular carcinoma cell line(HepG2) in the presence and absence of Zinc.”
- Journal: Anticancer agents in medicinal chemistry
- Publication Date: January 20, 2020
- Contributors: Karima Nasraldin
“Assessment of serum YKL-40 as a diagnostic biomarker and its discriminating power between different liver diseases”
- Journal: Bioscience Research
- Publication Date: 2018
- EID: 2-s2.0-85063176619
- Contributors: A.A. Fahmi, M. Ali El-Desouky, K.M. Nasraldin
“In Vitro Study to Compare the Apoptotic Effect of Natural Milk Thistle Tincture and Silymarin on Hepatocellular Carcinoma Cell Line (HepG2).”
- Event: 16th National Conference of Biochemistry and Molecular Biology Recent Trends in Biochemistry & Molecular Biology: Towards Vision 2030
- Date: September 14, 2019
- Type: Conference poster
These publications showcase Karima Mahmoud Nasraldin’s research focus on the anticancer effects of Amygdalin, particularly on hepatocellular carcinoma cell lines, and her involvement in evaluating diagnostic biomarkers for liver diseases.
Research Timeline:
Dr. Anasr’s research timeline reflects his dedication to advancing knowledge in biochemistry. Starting from his Master’s thesis on the role of Human Chitinase-3-like 1 in liver diseases to his recent publications on the anticancer effects of Amygdalin and cholecalciferol, his research journey has been marked by continuous exploration and discovery. He has consistently pursued innovative avenues of inquiry, contributing to the understanding and treatment of liver diseases.
Collaborations and Projects:
Dr. Anasr has collaborated with researchers and institutions both locally and internationally on various projects related to biochemistry and molecular biology. These collaborations have facilitated interdisciplinary approaches to research and have led to the development of innovative solutions for addressing complex scientific challenges. Additionally, Dr. Anasr has been involved in research projects focused on practical applications, such as the assessment of diagnostic biomarkers and the evaluation of therapeutic interventions for liver diseases.
